文献速递肺栓塞与肺血管病

免疫球蛋白驱动的补体激活调控肺动脉高压促炎性重塑

Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension.
PubMed 文献 · Am J Respir Crit Care Med · 2020-01-01

本研究探讨补体级联激活在实验性缺氧性肺动脉高压(PH)起始中的作用及其作为人类肺动脉高压(PAH)预后生物标志物的价值。通过免疫组化、基因缺陷小鼠、人肺外膜成纤维细胞培养及PAH患者血浆标志物网络医学分析,发现肺血管周围补体激活是PH和PAH的关键决定因素,且补体信号可预测PAH临床结局。

要点

  • 肺血管周围补体激活是实验性PH和人类PAH的一致关键决定因素。
  • 缺氧性PH的促炎和促增殖反应依赖补体替代途径和C5,IgG对补体激活至关重要。
  • 补体信号可作为PAH临床结局的预后因素。

核心结论

  • 免疫球蛋白驱动的补体激活失调是实验性缺氧性PH起始中调控促炎和促增殖过程的关键病理生物学机制。
  • 补体信号是人类PAH临床结局的关键决定因素。

研究设计与样本

  • 研究采用实验性PH模型和PAH患者肺组织免疫染色、缺乏特定补体成分或循环免疫球蛋白的基因小鼠模型分析、人肺动脉外膜成纤维细胞培养,以及PAH患者血浆生物标志物风险面板的网络医学分析。

主要发现

  • 在实验动物模型和人类中,肺血管周围特异性补体级联激活被确定为PH和PAH的一致关键决定因素。
  • 在实验性缺氧性PH中,促炎和促增殖反应依赖补体(替代途径和成分5),免疫球蛋白特别是IgG对补体级联激活至关重要。
  • Csf2/GM-CSF被确定为主要的补体依赖性炎症介质。
  • 对PAH患者血浆生物标志物风险面板的网络医学分析显示,补体信号可作为PAH临床结局的预后因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Pulmonary hypertension (PH) is a life-threatening cardiopulmonary disorder in which inflammation and immunity have emerged as critical early pathogenic elements. Although proinflammatory processes in PH and pulmonary arterial hypertension (PAH) are the focus of extensive investigation, the initiating mechanisms remain elusive.Objectives: We tested whether activation of the complement cascade is critical in regulating proinflammatory and pro-proliferative processes in the initiation of experimental hypoxic PH and can serve as a prognostic biomarker of outcome in human PAH.Methods: We used immunostaining of lung tissues from experimental PH models and patients with PAH, analyses of genetic murine models lacking specific complement components or circulating immunoglobulins, cultured human pulmonary adventitial fibroblasts, and network medicine analysis of a biomarker risk panel from plasma of patients with PAH.Measurements and Main Results: Pulmonary perivascular-specific activation of the complement cascade was identified as a consistent critical determinant of PH and PAH in experimental animal models and humans. In experimental hypoxic PH, proinflammatory and pro-proliferative responses were dependent on complement (alternative pathway and component 5), and immunoglobulins, particularly IgG, were critical for activation of the complement cascade. We identified Csf2/GM-CSF as a primary complement-dependent inflammatory mediator. Furthermore, using network medicine analysis of a biomarker risk panel from plasma of patients with PAH, we demonstrated that complement signaling can serve as a prognostic factor for clinical outcome in PAH.Conclusions: This study establishes immunoglobulin-driven dysregulated complement activation as a critical pathobiological mechanism regulating proinflammatory and pro-proliferative processes in the initiation of experimental hypoxic PH and demonstrates complement signaling as a critical determinant of clinical outcome in PAH.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Frid MG, McKeon BA, Thurman JM, et al. Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension. Am J Respir Crit Care Med. 2020. PMID: 31545648. doi:10.1164/rccm.201903-0591OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。